Industry
Biotechnology
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
July 01, 2024 | 10:55 am
Portfolio Pulse from Benzinga Newsdesk
June 14, 2024 | 12:50 pm
Portfolio Pulse from Benzinga Insights
June 12, 2024 | 12:06 pm
Portfolio Pulse from Benzinga Newsdesk
June 07, 2024 | 10:55 am
Portfolio Pulse from Avi Kapoor
May 30, 2024 | 6:48 pm
Portfolio Pulse from Avi Kapoor
May 30, 2024 | 4:00 pm
Portfolio Pulse from Avi Kapoor
May 30, 2024 | 1:55 pm
Portfolio Pulse from Avi Kapoor
May 30, 2024 | 12:10 pm
Portfolio Pulse from Benzinga Newsdesk
May 29, 2024 | 9:26 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.